martes, 13 de agosto de 2019

Few Americans took obesity drugs due to doctor doubts and cost- STAT

Few Americans took obesity drugs due to doctor doubts and cost- STAT

The Readout

Damian Garde

More reads

  • Novartis benefits from faster China drug approvals. (Financial Times)
  • Few Americans took obesity drugs thanks to doctor doubts and spotty insurance. (STAT Plus)
  • Better birth control could exist, but it wouldn’t pay for Big Pharma. (Bloomberg)

No hay comentarios: